Atlas Trials

A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC

Clinical trial NCT07547553 · RECRUITING

Trial details

NCT number
NCT07547553
Sponsor
Huahui Health
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Start date
2026-05-19
Primary completion
2028-10-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.